| Literature DB >> 33974912 |
Simone S Riedel1, Congcong Lu2, Hongbo M Xie3, Kevin Nestler1, Marit W Vermunt4, Alexandra Lenard1, Laura Bennett5, Nancy A Speck5, Ichiro Hanamura6, Julie A Lessard7, Gerd A Blobel8, Benjamin A Garcia2, Kathrin M Bernt9.
Abstract
Meningioma-1 (MN1) overexpression in AML is associated with poor prognosis, and forced expression of MN1 induces leukemia in mice. We sought to determine how MN1 causes AML. We found that overexpression of MN1 can be induced by translocations that result in hijacking of a downstream enhancer. Structure predictions revealed that the entire MN1 coding frame is disordered. We identified the myeloid progenitor-specific BAF complex as the key interaction partner of MN1. MN1 over-stabilizes BAF on enhancer chromatin, a function directly linked to the presence of a long polyQ-stretch within MN1. BAF over-stabilization at binding sites of transcription factors regulating a hematopoietic stem/progenitor program prevents the developmentally appropriate decommissioning of these enhancers and results in impaired myeloid differentiation and leukemia. Beyond AML, our data detail how the overexpression of a polyQ protein, in the absence of any coding sequence mutation, can be sufficient to cause malignant transformation.Entities:
Keywords: AML; BAF; IDP; IDR; Meningioma-1; SWI/SNF; intrinsically disordered protein/region; leukemia; polyQ
Mesh:
Substances:
Year: 2021 PMID: 33974912 PMCID: PMC8380056 DOI: 10.1016/j.molcel.2021.04.014
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 19.328